Skip to content

Humana

US · HUM #477 by market cap Listed 1970
390.00 +10.00 +2.63%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Price chart

Pre-market 393.00 +3.42%
After-hours 382.07 -2.03%
Overnight 385.12 +1.35%
461.25301.00390.002026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on HUM?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +39.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 2.3% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 38.0x Better than 15%
Forward P/E 21.6x Better than 32%
Price / Sales 0.3x Better than 96%
P/E vs own 5-yr range 95th pctl Better than 9%
Growth C-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 11.8% Better than 69%
Net income CAGR (3Y) -24.9% Better than 14%
Free cash flow CAGR (3Y) -52.3% Better than 4%
Profitability C

How much profit the business keeps from each dollar of sales and capital.

Net margin 0.9% Better than 29%
Return on equity 7.0% Better than 41%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 2.9% Better than 80%
6-month return 26.9% Better than 88%
12-month return (ex latest month) 87.4% Better than 94%
Distance below 52-week high 15.7% Better than 69%
Financial Health C-

Balance-sheet strength: leverage, liquidity and interest coverage.

Debt to assets 25.3% Better than 48%
Interest coverage 3.5x Better than 48%
Free cash flow / net income 31.6% Better than 8%
Analyst View B

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 76.2% Better than 56%
Upside to average target 31.9% Better than 51%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -13.33%
1M -8.75%
3M +2.43%
6M +28.54%
YTD +53.42%
1Y +76.58%
3Y -19.55%
5Y -5.89%

Key statistics

Price & volume

Prev close
380.00
Open
392.54
Day range
387.83 - 401.98
Avg price
393.46
Volume
2.32M
Turnover
911.56M
Amplitude
3.73%
52-week range
161.56 - 462.87

Valuation

P/E
39.63
P/E (TTM)
38.05
P/B
2.49
EPS
9.84
Net profit
1.18B
Net assets
18.82B

Share structure

Market cap
46.84B
Float cap
46.74B
Shares out
120.10M
Float shares
119.86M

Dividend & listing

Dividend (TTM)
2.66
Listing date
1970-01-01
52-week range 76% of range
161.56 462.87

15.7% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+39.02M net over the window

Short interest

Shares short
2.78M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Humana (HUM)?

Humana last traded at 390.00. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Humana's market cap?

About 46.84B.

What is the P/E ratio of Humana?

The trailing twelve-month P/E is 38.05, above its own 5-year average of 22.74 — toward the top of its historical range (94.58% percentile). See the Valuation tab for the full history.

Does Humana pay a dividend?

Yes. The trailing dividend yield is 0.68%. The 2025 payout was little changed from 2024. See the Dividends tab for the full payment history.

Is Humana a buy according to analysts?

The consensus of 21 analysts is a Buy rating, with an average 12-month price target of 514.25, which implies 31.9% upside from the current price. This is not investment advice.

What is Humana's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Humana a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:01:19 · For reference only, not investment advice and not tailored to your situation.

Humana discussion 0 comments

Add a comment